ArticleCell death & disease2025

The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer.

Yuxian Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.